Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients With Non-Small Cell Lung Cancer
- 1 April 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 34 (4) , 216-221
Abstract
Purpose: The aim of this study was to evaluate the diagnostic capacity of F-18 fluorodeoxyglucose dual-time-point (DTP) positron emission tomography (PET)/computed tomography (CT) for intrathoracic lymph node (LN) metastases in patients with nonsmall cell lung cancer (NSCLC). Materials and Methods: Thirty-four patients had DTP PET/CT, with 60 minutes and 2-hour scans (n = 19, NSCLC; n = 15, benign pulmonary disease). LN diagnoses were confirmed by surgery or clinical follow-up (n = 14, metastatic LNs; n = 45, nonmetastatic LNs; n = 39, inflammatory LNs). Results: The maximum standardized uptake value (SUVmax) in the metastatic group was significantly higher than those in the nonmetastatic and inflammatory groups on both early- and delayed-phase imaging (each P < 0.0001). The retention index (RI) of SUVmax (RI-SUVmax) in the metastatic group was significantly higher than in the nonmetastatic (P = 0.0008) and inflammatory groups (P = 0.0074). No significant difference was found between SUVmax values of the nonmetastatic and inflammatory groups on early- (P = 0.6461) or delayed-phase (P = 0.6913), or between RI-SUVmax values of the nonmetastatic and inflammatory groups (P = 0.5717). For early-phase SUVmax, the cut-off value for highest accuracy with metastatic LNs was 3.61, yielding a sensitivity of 86.67% and a specificity of 88.00%. For delayed-phase SUVmax, the cut-off value was 4.00, yielding a sensitivity of 91.6% and specificity of 92.9%. For RI-SUVmax, the cut-off value was 20.91%, yielding a sensitivity of 73.6% and specificity of 75.9%. Conclusions: DTP PET/CT with a semiquantitative technique may improve diagnostic capacity for nodal staging of NSCLC.Keywords
This publication has 17 references indexed in Scilit:
- Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F‐FDG PET/CT in a tuberculosis‐endemic countryCancer, 2007
- Maximum Standard Uptake Value of Mediastinal Lymph Nodes on Integrated FDG-PET-CT Predicts Pathology in Patients with Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2006
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- A comparative analysis of positron emission tomography and mediastinoscopy in staging non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2003
- The role of FDG-PET scan in staging patients with nonsmall cell carcinomaThe Annals of Thoracic Surgery, 2003
- Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot studyAnnals of Oncology, 1998
- Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomographyThe Journal of Thoracic and Cardiovascular Surgery, 1996
- T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT.Radiology, 1993
- Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.Radiology, 1992
- Mediastinal evaluation in lung cancer.Radiology, 1984